Albemarle Corporation Profile Avatar - Palmy Investing

Albemarle Corporation

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hy…
Chemicals - Specialty
US, Charlotte [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 0% Bad
Profitability n.A. n.A.
Fin. Growth 50% Balanced
Leverage & Liquidity 17% Weak
Per Share Metrics 67% Positive
Fin. Health n.A. n.A.
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 93.78 2.84 1.47
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -1932.31 -92.92 -4.57
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 22.43 98.19 80.20
Cash 130.83 17.50 7.58
Capex 15.38 -4.93 -5.83
Free Cash Flow 38.52 -4.10 -6.67
Revenue -42.30 11.59 20.08
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -90.97 0.03 -0.29
Operating Margin 72.11 -0.11 -0.38
ROA -99.62 < 0.005 -0.03
ROE -99.68 < 0.005 -0.07
ROIC 87.43 < 0.005 -0.07
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ALB is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ALB is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ALB is permitted for members.
End of ALB's Analysis
CIK: 915913 CUSIP: 012653101 ISIN: US0126531013 LEI: - UEI: -
Secondary Listings